18F-FAPI PET/CT performs better in evaluating mediastinal and hilar lymph nodes in patients with lung cancer: comparison with 18F-FDG PET/CT

18F-FAPI PET/CT performs better in evaluating mediastinal and hilar lymph nodes in patients with lung cancer: comparison with 18F-FDG PET/CT

Abstract Background The aim of this study was to evaluate the efficacy of fluorine 18 (18F) labeled fibroblast activation protein inhibitor (FAPI) in identifying mediastinal and hilar lymph node metastases and to develop a model to quantitatively and repeatedly identify lymph node status. Methods Tw...

Full description

Bibliographic Details
Main Authors: Yuyun Sun, Yun Sun, Zili Li, Shaoli Song, Kailiang Wu, Jingfang Mao, Jingyi Cheng
Format: Article
Language:English
Published: BMC 2024-01-01
Series:European Journal of Medical Research
Subjects:
18F-FAPI PET/CT
Mediastinal and hilar lymph node
Lung cancer
18F-FDG PET/CT
Online Access:https://doi.org/10.1186/s40001-023-01494-9

Internet

https://doi.org/10.1186/s40001-023-01494-9

Similar Items